Joint Venture Agreements in the Biotechnology Industry

36 Contracts & Agreements

Browse by Company

Aridis Pharmaceuticals, Inc. (1 contract)
Athenex, Inc. (1)
BeiGene, Ltd. (1)
Biogen Inc. (1)
BIOXYTRAN, INC (1)
CALADRIUS BIOSCIENCES, INC. (1)
Capstone Therapeutics Corp. (1)
CASI Pharmaceuticals, Inc. (1)
CRISPR Therapeutics AG (1)
CYTORI THERAPEUTICS, INC. (3)
Gritstone Oncology, Inc. (2)
GT Biopharma, Inc. (1)
HST Global, Inc. (1)
Kiromic Biopharma, Inc. (1)
KIWA BIO-TECH PRODUCTS GROUP CORP (1)
MATEON THERAPEUTICS INC (1)
MEDICINOVA INC (1)
NOVAVAX INC (3)
Orgenesis Inc. (4)
Pfenex Inc. (1)
PLURISTEM THERAPEUTICS INC (1)
REGENERX BIOPHARMACEUTICALS INC (1)
SOLENO THERAPEUTICS INC (1)
TG THERAPEUTICS, INC. (5)

Recent Contracts

Joint Venture Agreement relating to GMP Biotechnology Limited between Dragon Overseas Capital Limited, Oncotelic Therapeutics, Inc. and GMP Biotechnology Limited dated March 31,... (MATEON THERAPEUTICS INC, Filed With SEC on April 6, 2022)
Joint Venture Agreement, dated December 6, 2011, by and between Samsung BioLogics Co., Ltd. and Biogen Therapeutics Inc. (f/k/a Biogen Idec Therapeutics Inc.), as amended February... (Biogen Inc., Filed With SEC on April 22, 2021)
Joint Venture Agreement between Bioxytran and Pharmalectin Partners, LLC, dated November 15, 2020 (BIOXYTRAN, INC, Filed With SEC on April 9, 2021)
Joint venture agreement, dated 4.06.2020, between Molipharma S.R.L. and Kiromic BioPharma, Inc (Kiromic Biopharma, Inc., Filed With SEC on May 11, 2020)
Joint Venture Termination Agreement, dated December 13, 2019, among Bayer Healthcare LLC (and certain affiliates of Bayer Healthcare LLC for purposes of Article II), CRISPR... (CRISPR Therapeutics AG, Filed With SEC on February 12, 2020)
Joint Venture Agreement between the Company and KinerjaPay Corp. dated May 6, 2019 (Orgenesis Inc., Filed With SEC on May 8, 2019)
Joint Venture Agreement between the Company and First Choice International Company, Inc. dated March 12, 2019 (Orgenesis Inc., Filed With SEC on May 8, 2019)
Joint Venture Contract on Establishment of CASI (Wuxi) Pharmaceuticals Co. Ltd. by and between CASI Pharmaceuticals, Inc. and Wuxi Jintou Huicun Investment Enterprise Limited... (CASI Pharmaceuticals, Inc., Filed With SEC on March 29, 2019)
Lease Termination Agreement, by and between Gritstone Oncology, Inc. and Emery Station Joint Venture, LLC, effective as of January 28, 2019 (Gritstone Oncology, Inc., Filed With SEC on February 5, 2019)
Second Amended and Restated Joint Venture Agreement between Novavax, Inc. and Cadila Pharmaceuticals Limited, dated as of July 17, 2018 (NOVAVAX INC, Filed With SEC on November 7, 2018)
Amendment to the Joint Venture Contract in respect of Shenzen Arimab BioPharmaceutical Co., Ltd., by and between Shenzen Hepalink Pharmaceutical Group Co. and the Company,... (Aridis Pharmaceuticals, Inc., Filed With SEC on September 26, 2018)
Lease, dated as of November 11, 2015, by and between Gritstone Oncology, Inc. and Emery Station Joint Venture, LLC (Gritstone Oncology, Inc., Filed With SEC on August 23, 2018)
Joint Venture Agreement, dated as of December 4, 2017, by and among Soleno Therapeutics, Inc., Capnia, Inc., and OptAsia Healthcare Limited (SOLENO THERAPEUTICS INC, Filed With SEC on December 8, 2017)
JOINT VENTURE AGREEMENT (Athenex, Inc., Filed With SEC on May 12, 2017)
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [...***...]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE... (BeiGene, Ltd., Filed With SEC on May 10, 2017)
Joint Venture Agreement dated as of May 10, 2016 between Orgenesis Inc. and Atvio Biotech Ltd (Orgenesis Inc., Filed With SEC on April 19, 2017)
Joint Venture Agreement (Orgenesis Inc., Filed With SEC on February 28, 2017)
TERM SHEET BY AND BETWEEN PLURISTEM LTD. AND SOSEI CORPORATE VENTURE CAPITAL LTD. WITH RESPECT TO ESTABLISHMENT AND OPERATION OF A JOINT VENTURE December 19, 2016 (PLURISTEM THERAPEUTICS INC, Filed With SEC on February 8, 2017)
Amendment Two to Joint Venture Termination Agreement, dated January 8, 2016, by and between the Company and Olympus Corporation (filed with this Form 10-Q) (CYTORI THERAPEUTICS, INC., Filed With SEC on May 10, 2016)
JOINT VENTURE AGREEMENT (REGENERX BIOPHARMACEUTICALS INC, Filed With SEC on May 15, 2015)
PFENEX INC. AND AGILABIOTECH PRIVATE LIMITED JOINT VENTURE AGREEMENT JOINT VENTURE AGREEMENT (Pfenex Inc., Filed With SEC on June 5, 2014)
Joint Venture Termination Agreement dated May 8, 2013 by and between the Company and Olympus Corporation (CYTORI THERAPEUTICS, INC., Filed With SEC on May 10, 2013)
JOINTVENTURE AND LICENSE OPTION AGREEMENT BYAND BETWEEN TGTHERAPEUTICS, INC. AND RHIZENPHARMACEUTICALS S A (TG THERAPEUTICS, INC., Filed With SEC on November 14, 2012)
CAPSTONE THERAPEUTICS CORP. JOINT VENTURE BONUS PLAN (Capstone Therapeutics Corp., Filed With SEC on November 8, 2012)
JOINT VENTURE CONTRACT For Zhejiang Sunmy Medicine Biotechnology Corporation Limited June 29, 2011 TABLE OF CONTENTS (MEDICINOVA INC, Filed With SEC on August 15, 2011)
JOINT VENTURE AGREEMENT (GT Biopharma, Inc., Filed With SEC on July 12, 2011)
JointVenture Contract OF SUZHOUERYE PHARMACEUTICAL CO., LTD. Supersedingthe Version Executed on June 16, 2005 Amendedand Restated on October 21, 2009 (CALADRIUS BIOSCIENCES, INC., Filed With SEC on March 31, 2010)
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (NOVAVAX INC, Filed With SEC on August 10, 2009)
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (NOVAVAX INC, Filed With SEC on May 11, 2009)
OMNIBUS AMENDMENT TO JOINT VENTURE AGREEMENT AND ADDITIONAL AGREEMENTS (TG THERAPEUTICS, INC., Filed With SEC on October 3, 2008)
JOINT VENTURE AGREEMENT (TG THERAPEUTICS, INC., Filed With SEC on October 3, 2008)
OMNIBUS AMENDMENT TO JOINT VENTURE AGREEMENT AND ADDITIONAL AGREEMENTS (TG THERAPEUTICS, INC., Filed With SEC on June 13, 2008)
Contract for Joint Venture Between Hebei Huaxing Pharmaceuticals Co., Ltd. And Kiwa Bio-Tech Products Group Corporation Chapter 1 General Rules (KIWA BIO-TECH PRODUCTS GROUP CORP, Filed With SEC on May 27, 2008)
JOINT VENTURE AGREEMENT (TG THERAPEUTICS, INC., Filed With SEC on March 31, 2008)
JOINT VENTURE AGREEMENT (HST Global, Inc., Filed With SEC on May 16, 2006)
JOINTVENTURE AGREEMENT (CYTORI THERAPEUTICS, INC., Filed With SEC on March 30, 2006)